The treatment burden: is it all getting too much?

8 February 2023
Winter 2023

The effort, cost and logistics of managing treatment for eye conditions can have a big impact on patients’ quality of life. What can be done to minimise their treatment burden?

The idea that the “treatment burden” affects a patient’s adherence to medications, adaptations and attending ongoing appointments, and is linked to worse medical outcomes, is emerging in healthcare literature (Alsadah et al, 2022). A wide range of chronic eye conditions and comorbidities with other diseases can have an impact on a patient’s quality of life. From drops and lasers for primary open angle glaucoma to intravitreal injections for eye conditions such as diabetic macular oedema, treatment burden can be relevant to a variety of medical interventions.

Sign in to continue

Forgotten password?

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Mike Horler FCOptom presents current treatment strategies for late wet AMD, diabetic oedema and branch vein occlusion.


The General Optical Council (GOC) has presented a draft response to its call for evidence on the need for change to the Opticians Act (1989) and the consultation on associated GOC policies to its Council.

Members have been invited to have their say on the Guidance for Professional Practice - updated once every three years.